CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of LEE011 (Ribociclib) in Patients With Advanced Neuroendocrine Tumors of Foregut Origin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02420691
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:57.470732+00:00
Published At: 2020-10-30T00:00:00+00:00
Record Updated At: 2020-10-30
Results Posted At: 2020-10-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Digestive System Neuroendocrine Neoplasm", "Duodenal Neuroendocrine Tumor G1", "Functional Pancreatic Neuroendocrine Tumor", "Gastric Neuroendocrine Tumor", "Intermediate Grade Lung Neuroendocrine Neoplasm", "Low Grade Lung Neuroendocrine Neoplasm", "Nonfunctional Pancreatic Neuroendocrine Tumor", "Thymus Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-10-30"
protocolSection.identificationModule.nctId: "NCT02420691"
protocolSection.identificationModule.officialTitle: "A Phase II Study of LEE011 (Ribociclib) in Patients With Advanced Neuroendocrine Tumors of Foregut Origin"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-10-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.